Ertugliflozin: a new SGLT2 inhibitor for type 2 diabetes.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 34, doi. 10.1002/psb.1798
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2019 AND VI 30 AND IP 10
Results: 7
1
2
Suspected neurological conditions: when to refer.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 32, doi. 10.1002/psb.1797
- By:
- Publication type:
- Article
3
Diagnosis and treatment of eczema in children.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 28, doi. 10.1002/psb.1796
- By:
- Publication type:
- Article
4
Apalutamide for the treatment of non‐metastatic prostate cancer.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 26, doi. 10.1002/psb.1795
- By:
- Publication type:
- Article
5
Prescribing Simulator: new tool to develop prescribing skills.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 22, doi. 10.1002/psb.1794
- By:
- Publication type:
- Article
6
Obsessive‐compulsive disorder: current management options.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 14, doi. 10.1002/psb.1793
- By:
- Publication type:
- Article
7
The UK's ever‐changing prescribing landscape.
- Published in:
- Prescriber, 2019, v. 30, n. 10, p. 4, doi. 10.1002/psb.1792
- By:
- Publication type:
- Article